These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug-induced movement disorders. Jiménez-Jiménez FJ; García-Ruiz PJ; Molina JA Drug Saf; 1997 Mar; 16(3):180-204. PubMed ID: 9098656 [TBL] [Abstract][Full Text] [Related]
3. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients. Chouksey A; Pandey S Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():48. PubMed ID: 33178486 [TBL] [Abstract][Full Text] [Related]
4. Drug-induced movement disorders in children. Gilbert DL Ann N Y Acad Sci; 2008 Oct; 1142():72-84. PubMed ID: 18990122 [TBL] [Abstract][Full Text] [Related]
6. Tardive syndromes and other drug-induced movement disorders. Jankovic J Clin Neuropharmacol; 1995 Jun; 18(3):197-214. PubMed ID: 8635179 [No Abstract] [Full Text] [Related]
7. Tardive akathisia due to sulpiride. López de Munain A; Poza JJ; Gorospe A; Arce A; Martí Massó JF Clin Neuropharmacol; 1994 Oct; 17(5):481-3. PubMed ID: 9316700 [TBL] [Abstract][Full Text] [Related]
8. Side effects of antipsychotic drugs. Avoiding and minimizing their impact in elderly patients. Saltz BL; Woerner MG; Robinson DG; Kane JM Postgrad Med; 2000 Feb; 107(2):169-72, 175-8. PubMed ID: 10689415 [TBL] [Abstract][Full Text] [Related]
10. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia. Maat A; Fouwels A; de Haan L Psychopharmacol Bull; 2008; 41(3):5-10. PubMed ID: 18779773 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy. Musco S; Ruekert L; Myers J; Anderson D; Welling M; Cunningham EA J Clin Psychopharmacol; 2019; 39(4):336-343. PubMed ID: 31205194 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of akathisia in patients receiving stable doses of clozapine. Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study. Desai N; Patel PB; Shah S; Patel TK; Shah SN; Vatsala E Int J Psychiatry Clin Pract; 2018 Jun; 22(2):101-108. PubMed ID: 28952832 [TBL] [Abstract][Full Text] [Related]
15. Covert dyskinesia associated with aripiprazole: a case report and review of the literature. Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346 [TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced movement disorders - forgotten but not gone. Weiden PJ Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315 [No Abstract] [Full Text] [Related]
17. [Tardive dyskinesia: etiology, clinical features and therapy]. Furer V; Lichtenberg P; Heresco-Levy U Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354 [No Abstract] [Full Text] [Related]
18. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia. Barnes TR Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467 [TBL] [Abstract][Full Text] [Related]
19. Neuroleptic-induced akathisia and early onset tardive dyskinesia in affective disorder due to Cushing's syndrome. Brüne M; Schröder SG Gen Hosp Psychiatry; 1997 Nov; 19(6):445-7. PubMed ID: 9438189 [No Abstract] [Full Text] [Related]
20. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]